Stay updated with breaking news from 03475v10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) CEO James C. Clemmer purchased 10,000 shares of the firm’s stock in a transaction that occurred on Monday, April 8th. The shares were acquired at an average cost of $6.70 per share, for a total transaction of $67,000.00. Following the purchase, the chief executive officer now owns 539,066 […]
Oppenheimer upgraded shares of AngioDynamics (NASDAQ:ANGO – Free Report) from a market perform rating to an outperform rating in a report released on Friday morning, Marketbeat reports. Oppenheimer currently has $12.00 target price on the medical instruments supplier’s stock. A number of other analysts also recently issued reports on ANGO. Raymond James reduced their price […]
Oppenheimer upgraded shares of AngioDynamics (NASDAQ:ANGO – Free Report) from a market perform rating to an outperform rating in a report issued on Friday, Marketbeat Ratings reports. Oppenheimer currently has $12.00 price target on the medical instruments supplier’s stock. A number of other brokerages have also recently weighed in on ANGO. Raymond James reduced their […]
AngioDynamics (NASDAQ:ANGO – Get Free Report) and Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Earnings & Valuation This table compares AngioDynamics […]
AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 2,180,000 shares, an increase of 26.0% from the January 15th total of 1,730,000 shares. Based on an average daily trading volume, of 524,800 shares, […]